![Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology | Neuropsychopharmacology Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.npp.1300203/MediaObjects/41386_2003_Article_BF1300203_Fig1_HTML.gif)
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology | Neuropsychopharmacology
![PDF) Switching to Aripiprazole as a Strategy for Weight Reduction: A Meta-Analysis in Patients Suffering from Schizophrenia PDF) Switching to Aripiprazole as a Strategy for Weight Reduction: A Meta-Analysis in Patients Suffering from Schizophrenia](https://www.researchgate.net/publication/46428204/figure/fig1/AS:202802312814592@1425363247160/Mean-reduction-in-weight-kgs-across-analyzed-studies_Q320.jpg)
PDF) Switching to Aripiprazole as a Strategy for Weight Reduction: A Meta-Analysis in Patients Suffering from Schizophrenia
![Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding | Schizophrenia Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding | Schizophrenia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41537-022-00276-2/MediaObjects/41537_2022_276_Fig1_HTML.png)
Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding | Schizophrenia
![Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-00603/article_deploy/html/images/pharmaceuticals-16-00603-g001.png)
Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders
![Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-020-01566-w/MediaObjects/12325_2020_1566_Fig3_HTML.png)
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy
![Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/9adc3730-3918-4751-b84f-36c15f92acd7/gr3_lrg.jpg)
Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry
![Frontiers | The Association Between Antipsychotics and Weight Gain and the Potential Role of Metformin Concomitant Use: A Retrospective Cohort Study Frontiers | The Association Between Antipsychotics and Weight Gain and the Potential Role of Metformin Concomitant Use: A Retrospective Cohort Study](https://www.frontiersin.org/files/Articles/914165/fpsyt-13-914165-HTML/image_m/fpsyt-13-914165-g001.jpg)
Frontiers | The Association Between Antipsychotics and Weight Gain and the Potential Role of Metformin Concomitant Use: A Retrospective Cohort Study
![Aripiprazole Partial Agonism at 5-HT2C: A Comparison of Weight Gain Associated With Aripiprazole Adjunctive to Antidepressants With High Versus Low Serotonergic Activities | Psychiatrist.com Aripiprazole Partial Agonism at 5-HT2C: A Comparison of Weight Gain Associated With Aripiprazole Adjunctive to Antidepressants With High Versus Low Serotonergic Activities | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/12m01386t2.gif)
Aripiprazole Partial Agonism at 5-HT2C: A Comparison of Weight Gain Associated With Aripiprazole Adjunctive to Antidepressants With High Versus Low Serotonergic Activities | Psychiatrist.com
![Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis | Psychopharmacology Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis | Psychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00213-022-06233-2/MediaObjects/213_2022_6233_Fig2_HTML.png)
Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis | Psychopharmacology
![Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-020-01566-w/MediaObjects/12325_2020_1566_Fig2_HTML.png)
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy
![Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2021/06/20r02799T2.gif)
Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis | Psychiatrist.com
![Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan - Yun Tien, Hsiang-Ping Huang, Ding-Lieh Liao, Shang-Chien Huang, 2022 Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan - Yun Tien, Hsiang-Ping Huang, Ding-Lieh Liao, Shang-Chien Huang, 2022](https://journals.sagepub.com/cms/10.1177/20451253221113238/asset/images/large/10.1177_20451253221113238-fig1.jpeg)
Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan - Yun Tien, Hsiang-Ping Huang, Ding-Lieh Liao, Shang-Chien Huang, 2022
![Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning | Psychiatrist.com Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2021/04/LU18052AH1F3.gif)
Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning | Psychiatrist.com
![Frontiers | Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia Frontiers | Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia](https://www.frontiersin.org/files/Articles/770234/fpsyt-12-770234-HTML-r3/image_m/fpsyt-12-770234-g001.jpg)
Frontiers | Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia
![Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/912d2fe2-ec67-413f-88c7-211d02b25dc8/gr1_lrg.jpg)
Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry
![Frontiers | Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis Frontiers | Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/577919/577919_Thumb_400.jpg)